About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Drug Regimen Cuts Post-Op Nausea and Vomiting in Bariatric Weight Loss Surgery Patients

by Thilaka Ravi on October 14, 2013 at 1:05 PM
Font : A-A+

New Drug Regimen Cuts Post-Op Nausea and Vomiting in Bariatric Weight Loss Surgery Patients

Ninety-seven percent of bariatric surgery patients avoided post-operative nausea and vomiting (PONV) with the addition of a second drug to the standard treatment given during surgery, observes a study presented at the ANESTHESIOLOGY 2013 annual meeting.

"Nausea and vomiting are some of the most common post-op complications for all patients who have general anesthesia," said Ashish C. Sinha, M.D., Ph.D., vice chair of anesthesiology and perioperative medicine at Drexel University College of Medicine, Philadelphia. "However after weight-loss surgery, the consequences of vomiting can be very serious. During this kind of surgery, the stomach is transformed to a small, one-ounce sac. Vomiting risks rupturing the fresh incision as the contents of the stomach try to violently exit the narrow, freshly created stomach pouch. Reducing this risk would mean more comfortable patients as well as safer surgery and anesthesia."

Advertisement

An estimated 113,000 people in the United States have bariatric weight-loss surgery annually, according to the American Journal of Surgery. Approximately 15 million, or one in 50 American adults, are morbidly obese, which is associated with more than 30 diseases and conditions, including type 2 diabetes, heart disease, obstructive sleep apnea, hypertension, asthma, cancer, osteoarthritis and infertility. The direct and indirect costs to the health care system associated with obesity are about $147 billion annually, according to the American Society for Metabolic and Bariatric Surgery. These costs are expected to increase to $344 billion in five years, if obesity rates continue to increase at the current pace.

The study included 124 patients. Within one hour of the anticipated start of anesthesia, 64 people received the combination treatment of Zofran (the standard therapy) plus aprepitant; the remaining 60 patients got the Zofran and a placebo. Nausea was assessed with a 10-point scale after surgery at intervals of 30 minutes, one, two, six, 24 , 48 and 72 hours.
Advertisement

The study found that only three percent of patients who received the combination treatment experienced PONV. The incidence of vomiting was 15 percent in the placebo group who received Zofran alone.

"This multi-drug therapy can benefit patients at higher risk for PONV," continued Dr. Sinha. "There are multiple receptors in the brain stem that trigger vomiting; if we use the combination therapy, we can increase the number of receptors blocked and lower the incidence of vomiting."



Source: Newswise
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diet Pills Drug Toxicity Obesity The Cabbage Diet Vertigo Zone Diet Cholera Mediterranean Diet Clinical Trials - Different Phases of the trial Bulimia Nervosa 

Most Popular on Medindia

Noscaphene (Noscapine) Drug Interaction Checker Drug Side Effects Calculator Post-Nasal Drip Blood Pressure Calculator Nutam (400mg) (Piracetam) Diaphragmatic Hernia Hearing Loss Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Accident and Trauma Care

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR